<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract" xml:lang="en"><front><journal-meta><journal-id journal-id-type="nlm-ta">Trials</journal-id><journal-id journal-id-type="iso-abbrev">Trials</journal-id><journal-title-group><journal-title>Trials</journal-title></journal-title-group><issn pub-type="epub">1745-6215</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">4660284</article-id><article-id pub-id-type="publisher-id">1745-6215-16-S2-P149</article-id><article-id pub-id-type="doi">10.1186/1745-6215-16-S2-P149</article-id><article-categories><subj-group subj-group-type="heading"><subject>Poster Presentation</subject></subj-group></article-categories><title-group><article-title>Challenges in the design and analysis of a factorial-design cluster randomised trial</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="A1"><name><surname>Stephen</surname><given-names>Jacqueline</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A2"><name><surname>Lee</surname><given-names>Robert</given-names></name><xref ref-type="aff" rid="I3">3</xref></contrib><contrib contrib-type="author" id="A3"><name><surname>Kydonaki</surname><given-names>Kalliopi</given-names></name><xref ref-type="aff" rid="I2">2</xref></contrib><contrib contrib-type="author" id="A4"><name><surname>Antonelli</surname><given-names>Jean</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A5"><name><surname>Walsh</surname><given-names>Timothy S</given-names></name><xref ref-type="aff" rid="I2">2</xref></contrib><contrib contrib-type="author" id="A6"><name><surname>Weir</surname><given-names>Christopher J</given-names></name><xref ref-type="aff" rid="I3">3</xref><xref ref-type="aff" rid="I4">4</xref></contrib></contrib-group><aff id="I1"><label>1</label>Edinburgh Clinical Trials Unit, University of Edinburgh, Edinburgh, UK</aff><aff id="I2"><label>2</label>Anaesthetics, Critical Care and Pain Medicine, University of Edinburgh, Edinburgh, UK</aff><aff id="I3"><label>3</label>Centre for Population Health Sciences, University of Edinburgh, Edinburgh, UK</aff><aff id="I4"><label>4</label>Edinburgh Health Services Research Unit, Edinburgh, UK</aff><pub-date pub-type="collection"><year>2015</year></pub-date><pub-date pub-type="epub"><day>16</day><month>11</month><year>2015</year></pub-date><volume>16</volume><issue>Suppl 2</issue><supplement><named-content content-type="supplement-title">3rd International Clinical Trials Methodology Conference</named-content><named-content content-type="supplement-sponsor">Publication of this supplement was funded by the 3rd Clinical Trials Methodology Conference.</named-content></supplement><fpage>P149</fpage><lpage>P149</lpage><permissions><copyright-statement>Copyright Â© 2015 Stephen et al.</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Stephen et al.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><self-uri xlink:href="http://www.trialsjournal.com/content/16/S2/P149"></self-uri><conference><conf-date>16-17 November 2015</conf-date><conf-name>3rd International Clinical Trials Methodology Conference</conf-name><conf-loc>Glasgow, UK</conf-loc></conference></article-meta></front><body><sec><title><offsets xml_i="4221" xml_f="4233" txt_i="7" txt_f="19">Introduction</offsets></title><p><offsets xml_i="4244" xml_f="5107" txt_i="20" txt_f="883">Optimising sedation quality in mechanically ventilated intensive care patients is important because excessive sedation is associated with increased hospital acquired infections, longer intensive care (ICU) and hospital stay, and possibly higher mortality. The Development and Evaluation of Strategies to Improve Sedation Quality in InTensive Care (DESIST) study aims to optimise sedation practice. Here we focus on the study design, statistical analysis plan, performing the analysis and issues that occurred. DESIST randomised eight ICUs in pairs to four different combinations of sedation-related quality improvement interventions. The primary outcome assessed optimum sedation within each 12 hour nursing shift (referred to as a DESIST care period). This resulted in a three-level hierarchical data structure: DESIST care periods within admissions, within ICU.</offsets></p></sec><sec><title><offsets xml_i="5129" xml_f="5139" txt_i="885" txt_f="895">Challenges</offsets></title><p><offsets xml_i="5150" xml_f="5433" txt_i="896" txt_f="1179">The detailed analysis plan specified a generalised linear mixed model for the analysis of the primary outcome. Due to the complex hierarchical data structure, we used MLwiN which is specifically designed for the analysis of multilevel models. We will illustrate the use of the STATA </offsets><italic><offsets xml_i="5441" xml_f="5449" txt_i="1179" txt_f="1187">runmlwin</offsets></italic><offsets xml_i="5458" xml_f="5514" txt_i="1187" txt_f="1243"> command which allows MLwiN to be run from within STATA.</offsets></p><p><offsets xml_i="5521" xml_f="5736" txt_i="1244" txt_f="1459">Modelling ICU as both a fixed and random effect resulted in difficulties in model convergence and estimating the ICU level variance. There was non-normality of residuals and high auto-correlation within MCMC chains.</offsets></p></sec><sec><title><offsets xml_i="5758" xml_f="5768" txt_i="1461" txt_f="1471">Conclusion</offsets></title><p><offsets xml_i="5779" xml_f="6059" txt_i="1472" txt_f="1752">The small number of ICUs and lack of evidence of ICU-level clustering caused difficulties in fitting the three-level multilevel model. Fitting a simpler two-level model was feasible, gave similar intervention effect estimates and was justified by the lack of ICU-level clustering.</offsets></p></sec></body></article>